Federal Register / Vol. 87, No. 136 / Monday, July 18, 2022 / Notices 42731 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

Title of the Collection: ASPA COVID– 

19 Public Education Campaign Market 

Research. 

Type of Collection: Revision. 

OMB No. 0990–0476—Office of the 

Assistant Secretary for Public Affairs 

(ASPA) within Office of the Secretary. 

Abstract 

The Office of the Assistant Secretary 

for Public Affairs (ASPA), U.S. 

Department of Health and Human 

Services (HHS) is requesting a revision 

on a currently approved collection 

including three components: 1. Current 

Events Tracker (CET), 2. Qualitative 

data collection in the form of focus 

groups, interviews, and dyads, and 3. 

Copy testing surveys. This revision 

supports continuation of the approved 

data collection by adding burden and 

iterations to support the program during 

the ongoing COVID–19 public health 

emergency and through the expiration 

of the package 0990–0476 in early 2024. 

Together, these efforts support the 

development and execution of the 

COVID–19 Public Education Campaign. 

The broad purpose of each effort is as 

follows: 

Current Events Tracker 

The primary purpose of the COVID– 

19 Current Events Tracker (CET) survey 

is to continuously track key metrics of 

importance to the Campaign, including 

vaccine confidence and uptake, 

familiarity with and trust in HHS and 

other trusted messengers, and the 

impact of external events on key 

attitudes and behaviors. This 

information will inform Campaign 

development and execution including 

changes in messaging strategies 

necessary to effectively reach the entire 

U.S. population or specific subgroups. 

Focus Groups/Interviews/Dyads 

ASPA is collecting information 

qualitatively to inform the Campaign 

about audience risk knowledge, 

perceptions, current behaviors, and 

barriers and motivators to healthy 

behaviors (including COVID–19 

vaccination). Ultimately these focus 

groups, interviews, and/or dyads will 

provide in-depth insights regarding 

information needed by Campaign 

audiences as well as their attitudes and 

behaviors related to COVID–19 and the 

COVID–19 vaccines. These will be used 

to inform the development of Campaign 

messages and strategy. 

Copy Testing Surveys 

Prior to placing Campaign 

advertisements in market, ASPA will 

conduct copy testing surveys to ensure 

the final Campaign messages have the 

intended effect on target attitudes and 

behaviors. Copy testing surveys will be 

conducted with sample members who 

comprise the target audiences; these 

surveys will assess perceived 

effectiveness of the advertisements as 

well as the effect of exposure to an ad 

on key attitudes and behavioral 

intentions. The results from these 

surveys will be used internally by ASPA 

to inform decisions on Campaign 

messages and materials; for example, to 

identify revisions to the materials or 

determine which advertisement to move 

to market. 

ESTIMATED ANNUALIZED BURDEN TABLE

Type of respondent Form name Number of 

respondents 

Number 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

CET ................................................... CET Questionnaire ........................... a 138,000 1 7.2/60 16,560 

Foundational Focus Groups, Interviews, and/or Dyads b.Screener and Interview .................... c 50,000 1 9.3/60 7,750 

Copy Testing Survey ........................ Screener and Survey ....................... d 540,000 1 3.78/60 34,020 

Sum of All Studies ..................... ........................................................... 728,000 ........................ ........................ 58,330 

Sherrette A. Funn, 

Paperwork Reduction Act Reports Clearance 

Officer, Office of the Secretary. 

[FR Doc. 2022–15235 Filed 7–15–22; 8:45 am] 

BILLING CODE 4150–25–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Neurobiology of Pain and Itch. 

Date: July 29, 2022. 

Time: 1:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: M. Catherine Bennett, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5182, 

MSC 7846, Bethesda, MD 20892, (301) 435– 

1766, bennettc3@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: July 13, 2022. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–15283 Filed 7–15–22; 8:45 am] 

BILLING CODE 4140–01–P 


khammond on DSKJM1Z7X2PROD with NOTICES